IRIS
LATTANZIO, ROSSANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.879
AS - Asia 3.243
EU - Europa 3.129
SA - Sud America 447
AF - Africa 80
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.748
SG - Singapore 1.435
IT - Italia 852
CN - Cina 751
IE - Irlanda 436
VN - Vietnam 384
BR - Brasile 373
RU - Federazione Russa 305
SE - Svezia 305
UA - Ucraina 247
GB - Regno Unito 240
DE - Germania 223
TR - Turchia 220
FR - Francia 183
IN - India 134
FI - Finlandia 94
CA - Canada 75
HK - Hong Kong 62
AT - Austria 47
BD - Bangladesh 45
JP - Giappone 38
PL - Polonia 35
ZA - Sudafrica 35
NL - Olanda 34
MX - Messico 32
AR - Argentina 27
CZ - Repubblica Ceca 27
IQ - Iraq 26
BE - Belgio 21
ES - Italia 21
EC - Ecuador 15
PH - Filippine 15
PK - Pakistan 14
KR - Corea 13
UZ - Uzbekistan 13
AU - Australia 12
LT - Lituania 12
SA - Arabia Saudita 12
ID - Indonesia 11
TH - Thailandia 11
MY - Malesia 9
CH - Svizzera 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
KE - Kenya 7
TN - Tunisia 7
BG - Bulgaria 6
CO - Colombia 6
DZ - Algeria 6
HN - Honduras 6
IR - Iran 6
JO - Giordania 6
UY - Uruguay 6
PY - Paraguay 5
RS - Serbia 5
AO - Angola 4
BO - Bolivia 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
RO - Romania 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
NG - Nigeria 3
SR - Suriname 3
CL - Cile 2
CR - Costa Rica 2
CU - Cuba 2
DO - Repubblica Dominicana 2
EU - Europa 2
GD - Grenada 2
HR - Croazia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
Totale 11.788
Salva come PNG Salva come JPEG
Città #
Singapore 1.093
San Jose 594
Chandler 498
Dublin 427
Ashburn 411
Jacksonville 328
Beijing 220
Dallas 162
Princeton 160
Santa Clara 155
Los Angeles 152
Ho Chi Minh City 141
Council Bluffs 126
New York 126
Southend 124
Pescara 115
Dearborn 112
The Dalles 110
Chieti 104
Izmir 102
Nanjing 96
Ann Arbor 78
Wilmington 74
Altamura 73
Hanoi 73
Hong Kong 55
Munich 55
Boardman 54
Cambridge 50
Orem 42
Tongling 42
Moscow 41
São Paulo 41
Rome 40
Redondo Beach 39
Collecorvino 36
Dong Ket 34
Denver 33
Vienna 33
Milan 32
Nanchang 31
London 29
Houston 28
Buffalo 27
Johannesburg 27
Shenyang 27
Tokyo 27
Montreal 26
Washington 26
Brooklyn 25
Chicago 24
Woodbridge 24
Warsaw 23
Frankfurt am Main 21
Hebei 21
Hefei 21
Turku 21
Ancona 20
Chennai 20
Atlanta 19
Brussels 18
Seattle 18
Stockholm 18
Amsterdam 17
Brno 17
Catania 17
Nuremberg 17
Tianjin 17
Helsinki 16
Jiaxing 16
Boston 15
Da Nang 15
Lappeenranta 15
San Vito Chietino 15
Ankara 13
Haiphong 13
Mumbai 13
Poplar 13
Rio de Janeiro 13
St Louis 13
Grevenbroich 12
Jinan 12
Manchester 12
Messina 12
Mexico City 12
Phoenix 12
Bologna 11
Seoul 11
Kunming 10
San Francisco 10
Tashkent 10
Toronto 10
Bangkok 8
Biên Hòa 8
Charlotte 8
Guayaquil 8
Macerata 8
Medford 8
Norwalk 8
Shanghai 8
Totale 7.275
Salva come PNG Salva come JPEG
Nome #
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 255
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 244
A unique four-hub protein cluster associates to glioblastoma progression 220
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 217
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 208
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 205
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 191
Trop-2 is a determinant of breast cancer survival. 188
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 170
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 169
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 169
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 165
ABCC3 is a novel target for the treatment of pancreatic cancer 165
Upregulation of Trop-2 quantitatively stimulates human cancer growth 164
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 163
Prognostic relevance of LGALS3BP in human colorectal carcinoma 159
The Trop-2 signalling network in cancer growth 158
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 158
Exosomes as pleiotropic players in pancreatic cancer 158
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 157
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 154
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 153
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 151
Molecular studies of pulmonary carcinoids 150
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 150
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 149
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 149
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 148
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 147
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 146
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 144
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 143
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 142
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 139
[Tissue microarrays] 136
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 135
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 135
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 135
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 134
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 134
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 134
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 132
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 131
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 129
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 129
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 128
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 127
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 127
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 126
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 123
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 123
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 123
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 122
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 118
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 117
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 115
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 114
Pioneers in Pathology 113
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 113
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 112
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 112
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 112
Role of phospholipase C in cell invasion and metastasis 112
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 111
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 111
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 110
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 109
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 108
Phospholipase Cgamma1 is required for metastasis development and progression 108
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 107
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 105
Loss of primary cilia promotes inflammation and carcinogenesis 101
The role of phospholipase Cγ1 in breast cancer and its clinical significance 101
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 99
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 95
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 95
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 93
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 92
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 91
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 90
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 86
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 86
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 85
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 85
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 82
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 81
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 80
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 75
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 71
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 70
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 70
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 65
null 57
Novel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report 55
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 49
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 41
null 41
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 29
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 26
null 21
Totale 12.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022512 17 7 25 126 14 47 10 24 31 22 64 125
2022/20231.337 104 236 78 135 138 219 69 121 138 17 42 40
2023/2024908 52 28 67 38 52 288 175 42 25 31 12 98
2024/20252.347 89 439 375 88 76 114 161 146 241 144 227 247
2025/20264.564 357 171 363 629 517 284 740 262 450 417 272 102
Totale 12.337